PFGIA
AXSM icon

Patriot Financial Group Insurance Agency’s Axsome Therapeutics AXSM Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-250
Closed -$10K – 2009
2022
Q1 		$10K Hold
250
– – ﹤0.01% 1344
2021
Q4 		$9K Buy
250
+100
+67% +$3.68K ﹤0.01% 1512
2021
Q3 		$5K Buy
+150
New +$5.85K ﹤0.01% 1675

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Patriot Financial Group Insurance Agency's AXSM Position: Q2 2022 in Review

Patriot Financial Group Insurance Agency sold out of Axsome Therapeutics (AXSM) in Q2 2022, closing a stake of 250 shares — an estimated $10K sold.

Patriot Financial Group Insurance Agency first reported a position in AXSM in Q3 2021 and held it in 3 quarters. The position peaked at $10K in Q1 2022. 174 funds tracked by Wall St. Rank hold AXSM as of Q2 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Axsome Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 250 Axsome Therapeutics shares in Q2 2022, an estimated $10K.
  • Patriot Financial Group Insurance Agency first reported a position in Axsome Therapeutics in Q3 2021 and held it in 3 quarters.
  • Patriot Financial Group Insurance Agency's Axsome Therapeutics position peaked at $10K in Q1 2022.
  • 174 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q2 2022, filed 29 Jul 2022.